Key facts
- It has raised $5.3M; the latest was Later Stage VC in Nov 2025.
- Notable investors include Enterprise Ireland, European Innovation Council, MedTech Innovator, European Union, Texas Medical Center — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for InVera Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for InVera Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About InVera Medical
Developer of proprietary medical devices designed for the treatment of all chronic venous disease sufferers. The company's device offers minimally invasive, pain-free endovenous treatment that uses the body's natural biological response to cure varicose veins and venous ulcers, enabling patients to receive safe and effective care for varicose veins and venous ulcers.
- Sector
- Healthcare
- HQ
- Galway, Ireland
- Founded
- 2017
- Employees
- 9
- Website
- inveramedical.com/
- Ownership
- Privately Held (backing)
InVera Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in InVera Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on InVera Medical in its N-PORT filings yet. We sweep new filings monthly.